Rigel Pharmaceuticals (RIGL) Leases (2019 - 2025)
Historic Leases for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Q3 2025 value amounting to $1.0 million.
- Rigel Pharmaceuticals' Leases rose 15925.93% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 15925.93%. This contributed to the annual value of $246000.0 for FY2024, which is 7142.86% down from last year.
- Rigel Pharmaceuticals' Leases amounted to $1.0 million in Q3 2025, which was up 15925.93% from $1.2 million recorded in Q2 2025.
- Rigel Pharmaceuticals' Leases' 5-year high stood at $15.9 million during Q1 2021, with a 5-year trough of $246000.0 in Q4 2024.
- Over the past 5 years, Rigel Pharmaceuticals' median Leases value was $1.2 million (recorded in 2025), while the average stood at $4.1 million.
- In the last 5 years, Rigel Pharmaceuticals' Leases crashed by 8509.03% in 2023 and then soared by 15925.93% in 2025.
- Quarter analysis of 5 years shows Rigel Pharmaceuticals' Leases stood at $9.7 million in 2021, then crashed by 80.11% to $1.9 million in 2022, then plummeted by 55.39% to $861000.0 in 2023, then plummeted by 71.43% to $246000.0 in 2024, then skyrocketed by 326.83% to $1.0 million in 2025.
- Its Leases stands at $1.0 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.3 million for Q1 2025.